Skip to main content

Table 3 Validation of RSKC through random baseline clustering. This table shows the scores corresponding to the best clustering result, the average and the mean value from the 1000 random datasets, comparing it with the reference scores

From: Disclosing transcriptomics network-based signatures of glioma heterogeneity using sparse methods

Case

K

Reference score

Random score (Best – Average – Median)

Silhouette

Calinski-Harabasz

Silhouette

Calinski-Harabasz

(A) LGG vs GBM

2

0.70

640.95

0.72 — 0.52 — 0.52

668.21 — 170.93 — 158.06

3

0.62

746.37

0.59 — 0.33 — 0.34

247.07 — 66.21 — 60.47

(B) Astrocytoma vs Oligodendroglioma

2

0.58

513.29

0.74 — 0.45 — 0.46

264.50 — 57.91 — 46.17

3

0.59

526.92

0.60 — 0.32 — 0.31

61.16 — 8.24 — 6.92

(C) Astrocytoma vs Oligodendroglioma vs GBM

2

0.73

843.31

0.73 — 0.51 — 0.52

497.87 — 153.68 — 142.14

3

0.61

753.07

0.64 — 0.33 — 0.33

300.62 — 62.19 — 55.98

  1. Cases A, B and C represent our cases of study, respectively, ‘LGG vs GBM’, ‘Astrocytoma vs Oligodendroglioma’, and ‘Astrocytoma vs Oligodendroglioma vs GBM’
  2. LGG lower-grade glioma, GBM glioblastoma